DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery

Recruiting Observational Study
Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
80 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Research network
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
DMEK (Descemet Membrane Endothelial Keratoplasty) is a surgical technique used to treat primary or secondary corneal endothelial decompensation. At the Rothschild Foundation, as in many Western referral centers, DMEK is currently the surgical technique of choice for the treatment of primary or secondary corneal endothelial decompensation. Technically challenging, it is a relatively tedious surger…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria : * Patients scheduled for corneal endothelial transplantation in one or both eyes * History of vitrectomy, trabeculectomy, large iris defects, anterior synechiae on the eye to be operated on * Pseudophakia or aphakia in the eye to be operated on * Express consent to participate …
Contacts

Amélie YAVCHITZ

01.48.03.64.33

ayavchitz@for.paris

CONTACT